| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.582 | 19.650 | 23.839 | 21.759 | 37.171 | 18.461 | 0 | 1.804 | 0 | 0 |
| Total Income - EUR | 9.583 | 19.650 | 23.839 | 21.759 | 37.171 | 18.465 | 0 | 1.804 | 202 | 0 |
| Total Expenses - EUR | 5.975 | 6.730 | 17.729 | 21.486 | 21.306 | 2.975 | 804 | 101 | 1.255 | 76 |
| Gross Profit/Loss - EUR | 3.608 | 12.920 | 6.110 | 273 | 15.864 | 15.490 | -804 | 1.702 | -1.053 | -76 |
| Net Profit/Loss - EUR | 3.320 | 12.331 | 5.517 | 55 | 15.493 | 14.936 | -804 | 1.649 | -1.053 | -76 |
| Employees | 0 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Remedium S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 804 | 796 | 782 | 768 | 1.307 | 1.222 | 1.136 | 1.080 | 0 | 0 |
| Current Assets | 19.535 | 31.668 | 38.393 | 36.823 | 40.758 | 54.577 | 5.999 | 7.822 | 7.727 | 7.677 |
| Inventories | 281 | 10 | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 13.821 | 30.777 | 37.748 | 35.687 | 38.578 | 41.609 | 5.999 | 6.018 | 7.521 | 7.479 |
| Cash | 5.432 | 880 | 636 | 1.126 | 2.179 | 12.968 | 0 | 1.804 | 206 | 197 |
| Shareholders Funds | 20.084 | 32.211 | 37.183 | 36.556 | 41.089 | 55.246 | 7.135 | 8.807 | 7.727 | 7.616 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 254 | 253 | 1.993 | 1.035 | 976 | 554 | 0 | 95 | 0 | 60 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Remedium S.r.l.